573
Views
47
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLECausation and Prevention

Prevention of Breast Cancer (Part I): Epidemiology, Risk Factors, and Risk Assessment Tools

, &
Pages 743-750 | Published online: 16 Jul 2010

REFERENCES

  • Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Murray, T.; Thun, M.J. Cancer statistics, CA Cancer J Clin 2008, 58, 71–96.
  • Garcia, M.; Jemal, A.; Ward, E.M.; Center, M.M.; Hao, Y.; Siegel, R.L.; Thun, M.J. Global Cancer Facts & Figures 2007. Atlanta, GA: American Cancer Society, 2007.
  • Berry, D.A.; Cronin, K.A.; Plevritis, S.K.; Fryback, D.G.; Clarke, L.; Zelen, M.; Mandelblatt, J.S.; Yakovlev, A.Y.; Habbema, J.D.; Feuer, E.J.; Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005, 353, 1784–1792.
  • American Cancer Society. Cancer Facts & Figures 2008. Atlanta: American Cancer Society, 2008.
  • Jatoi, I.; Chen, B.E.; Anderson, W.F.; Rosenberg, P.S. Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis. J Clin Oncol 2007, 25, 1683–1690.
  • Ravdin, P.M.; Cronin, K.A.; Howlader, N.; Berg, C.D.; Chlebowski, R.T.; Feuer, E.J.; Edwards, B.K.; Berry, D.A. The decrease in breast cancer incidence in 2003 in the United States. N Engl J Med 2007, 356, 1670–1674.
  • Horner, M.J.; Ries, L.A.G.; Krapcho, M.; Neyman, N.; Aminou, R.; Howlader, N.; Altekruse, S.F.; Feuer, E.J.; Huang, L.; Mariotto, A.; Miller, B.A.; Lewis, D.R.; Eisner, M.P.; Stinchcomb, D.G.; Edwards, B.K. (eds.). SEER Cancer Statistics Review, 1975–2006. Bethesda, MD: National Cancer Institute, http://seer.cancer.gov/csr/1975_2006/ , based on November 2008 SEER data submission, posted to the SEER web site, 2009.
  • Bradley, C.J.; Given, C.W.; Roberts, C. Race, socioeconomic status and breast cancer treatment and survival. J Natl Cancer Inst 2002, 94, 490–496.
  • Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 2001, 358, 1389–1399.
  • Carey, L.A.; Perou, C.M.; Livasy, C.A.; Dressler, L.G.; Cowan, D.; Conway, K.; Karaca, G.; Troester, M.A.; Tse, C.K.; Edmiston, S.; Deming, S.L.; Geradts, J.; Cheang, M.C.; Nielsen, T.O.; Moorman, P.G.; Earp, H.S.; Millikan, R.C. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006, 295, 2492–2502.
  • Jones, L.A.; Chilton, J.A. Impact of breast cancer on African American women: priority areas for research in the next decade. Am J Public Health 2002, 92, 539–542.
  • Health Disparities Research and Programs: Minority & Women Clinical Trials Recruitment Program. (http://www.mdanderson.org/education-and-research/research- at-md-anderson/index.html).
  • Ford, D.; Easton, D.F.; Stratton, M.; Narod, S.; Goldgar, D.; Devilee, P.; Bishop, D.T.; Weber, B.; Lenoir, G.; Chang-Claude, J.; Sobol, H.; Teare, M.D.; Struewing, J.; Arason, A.; Scherneck, S.; Peto, J.; Rebbeck, T.R.; Tonin, P.; Neuhausen, S.; Barkardottir, R.; Eyfjord, J.; Lynch, H.; Ponder, B.A.; Gayther, S.A.; Zelada-Hedman, M. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998, 62, 676–689.
  • Ready, K.J.; Arun, B.K. Genetic predisposition to breast cancer and genetic counseling and testing. In Breast Cancer, K.K. Hunt, G.L. Robb, E.A. Strom, and N.T. Ueno (eds.). New York, NY: Springer Science + Business Media, LLC, 2008, 64–66.
  • Hsieh, C.C.; Trichopoulos, D.; Katsouyanni, K.; Uuasa, S. Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: associations and interactions in an international case-control study. Int J Cancer 1990, 46, 796–800.
  • Brinton, L.A.; Schairer, C.; Hoover, R.N.; Farumeni, J.F. Menstrual factors and risk of breast cancer. Cancer Invest 1988, 6, 245–254.
  • Feuer, E.J.; Wun, L.M.; Boring, C.C.; Flanders, W.D.; Timmel, M.J.; Tong, T. The lifetime risk of developing breast cancer. J Natl Cancer Inst 1993, 85(11), 892–897.
  • Chlebowski, R.T.; Hendrix, S.L.; Langer, R.D.; Stefanick, M.L.; Gass, M.; Lane, D.; Rodabough, R.J.; Gilligan, M.A.; Cyr, M.G.; Thomson, C.A.; Khandekar, J.; Petrovitch, H.; McTiernan, A.; WHI Investigators. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA 2003, 289, 3243–3253.
  • Anderson, G.L.; Limacher, M.; Assaf, A.R.; Bassford, T.; Beresford, S.A.; Black, H.; Bonds, D.; Brunner, R.; Brzyski, R.; Caan, B.; Chlebowski, R.; Curb, D.; Gass, M.; Hays, J.; Heiss, G.; Hendrix, S.; Howard, B.V.; Hsia, J.; Hubbell, A.; Jackson, R.; Johnson, K.C.; Judd, H.; Kotchen, J.M.; Kuller, L.; LaCroix, A.Z.; Lane, D.; Langer, R.D.; Lasser, N.; Lewis, C.E.; Manson, J.; Margolis, K.; Ockene, J.; O'sullivan, M.J.; Phillips, L.; Prentice, R.L.; Ritenbaugh, C.; Robbins, J.; Rossouw, J.E.; Sarto, G.; Stefanick, M.L.; Van Horn, L.; Wactawski-Wende, J.; Wallace, R.; Wassertheil-Smoller, S.; Women's Health Initiative Steering Committee. Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative Randomized Trial. JAMA 2004, 291, 1701–1712.
  • Collaborative Group on Hormonal Factors in Breast Cancer. Breast Cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100, 239 women without breast cancer from 54 epidemiological studies. Lancet 1996, 347, 1713–1727.
  • Marchbanks, P.A.; McDonald, J.A.; Wilson, H.G.; Folger, S.G.; Mandel, M.G.; Daling, J.R.; Bernstein, L.; Malone, K.E.; Ursin, G.; Strom, B.L.; Norman, S.A.; Wingo, P.A.; Burkman, R.T.; Berlin, J.A.; Simon, M.S.; Spirtas, R.; Weiss, L.K. Oral contraceptives and the risk of breast cancer. N Engl J Med 2002, 346, 2025–2032.
  • Lynn C. Hartmann; M.D.; Thomas A. Sellers; Ph.D.; Marlene H. Frost; Ph.D.; Wilma L. Lingle; Ph.D.; Amy C. Degnim; M.D.; Karthik Ghosh; M.D.; Robert A. Vierkant; M.A.S.; Shaun D. Maloney; B.A.; V. Shane Pankratz; Ph.D.; David W. Hillman; M.S.; Vera J. Suman; Ph.D.; J.o. Johnson; R.N.; Cassann Blake; M.D.; Thea Tlsty; Ph.D.; Celine M. Vachon; Ph.D.; L. Joseph Melton; III; M.D., and Daniel W. Visscher; M.D. Benign breast disease and the risk of breast cancer. N Engl Med 2005, 353, 229–237.
  • Degnim, A.C.; Visscher, D.W.; Berman, H.K.; Frost, M.H.; Sellers, T.A.; Vierkant, R.A.; Maloney, S.D.; Pankratz, V.S.; de Groen, P.C.; Lingle, W.L.; Ghosh, K.; Penheiter, L.; Tlsty, T.; Melton, L.J. 3rd; Reynolds, C.A.; Hartmann, L.C. Stratification of breast cancer risk in women with atypia: a Mayo cohort study. J Clin Oncol 2007, 25, 2671–2677.
  • Arpino, G.; Laucirica, R.; Elledge, R.M. Premalignant and in situ breast disease: biology and clinical implications. Ann Intern Med 2005, 143, 446–457.
  • John, E.M.; Kelsey, J.L. Radiation and other environmental exposures and breast cancer. Epidemiol Rev 1993, 15, 157–162.
  • Ronckers, C.M.; Erdmann, C.A.; Land, C.E. Radiation and breast cancer: a review of current evidence. Breast Cancer Res 2005, 7, 21–32.
  • Kenney, L.B.; Yasui, Y.; Inskip, P.D.; Hammond, S.; Neglia, J.P.; Mertens, A.C.; Meadows, A.T.; Friedman, D.; Robison, L.L.; Diller, L. Breast cancer after childhood cancer: a report from the childhood cancer survivor study. Ann Intern Med 2004, 141, 590–597.
  • Fisher, B.; Dignam, J.; Wolmark, N.; Wickerham, D.L.; Fisher, E.R.; Mamounas, E.; Smith, R.; Begovic, M.; Dimitrov, N.V.; Margolese, R.G.; Kardinal, C.G.; Kavanah, M.T.; Fehrenbacher, L.; Oishi, R.H. Tamoxifen in treatment of intraductal breast cancer: national surgical adjuvant breast and bowel project B-24 randomized controlled trial. Lancet 1999, 353, 1993–2000.
  • Thiébaut, A.C.; Kipnis, V.; Chang, S.C.; Subar, A.F.; Thompson, F.E.; Rosenberg, P.S.; Hollenbeck, A.R.; Leitzmann, M.; Schatzkin, A. Dietary fat and postmenopausal invasive breast cancer in the national institutes of health-AARP diet and health study cohort. J Natl Cancer Inst 2007, 99, 451–462.
  • Hunter, D.J.; Spiegelman, D.; Adami, H.O.; Beeson, L.; Van Den Brandt, P.A.; Folsom, A.R.; Fraser, G.E.; Goldbohm, R.A.; Graham, S.; Howe, G.R. Cohort studies of fat intake and the risk of breast cancer – a pooled analysis. N Engl J Med 1996, 334, 356–361.
  • Prentice, R.L.; Caan, B.; Chlebowski, R.T.; Patterson, R.; Kuller, L.H.; Ockene, J.K.; Margolis, K.L.; Limacher, M.C.; Manson, J.E.; Parker, L.M.; Paskett, E.; Phillips, L.; Robbins, J.; Rossouw, J.E.; Sarto, G.E.; Shikany, J.M.; Stefanick, M.L.; Thomson, C.A.; Van Horn, L.; Vitolins, M.Z.; Wactawski-Wende, J.; Wallace, R.B.; Wassertheil-Smoller, S.; Whitlock, E.; Yano, K.; Adams-Campbell, L.; Anderson, G.L.; Assaf, A.R.; Beresford, S.A.; Black, H.R.; Brunner, R.L.; Brzyski, R.G.; Ford, L.; Gass, M.; Hays, J.; Heber, D.; Heiss, G.; Hendrix, S.L.; Hsia, J.; Hubbell, F.A.; Jackson, R.D.; Johnson, K.C.; Kotchen, J.M.; LaCroix, A.Z.; Lane, D.S.; Langer, R.D.; Lasser, N.L.; Henderson, M.M. Low-fat dietary pattern and risk of invasive breast cancer: the women's health initiative randomized controlled dietary modification trial. JAMA 2006, 295, 629–642.
  • Howard, B.V.; Manson, J.E.; Stefanick, M.L.; Beresford, S.A.; Frank, G.; Jones, B.; Rodabough, R.J.; Snetselaar, L.; Thomson, C.; Tinker, L.; Vitolins, M.; Prentice, R. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA 2006, 295(1), 39–49.
  • Howard, B.V.; Manson, J.E.; Stefanick, M.L.; Beresford, S.A.; Frank, G.; Jones, B.; Rodabough, R.J.; Snetselaar, L.; Thomson, C.; Tinker, L.; Vitolins, M.; Prentice, R. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006, 295(6), 655–666.
  • Pierce, J.P.; Natarajan, L.; Caan, B.J.; Parker, B.A.; Greenberg, E.R.; Flatt, S.W.; Rock, C.L.; Kealey, S.; Al-Delaimy, W.K.; Bardwell, W.A.; Carlson, R.W.; Emond, J.A.; Faerber, S.; Gold, E.B.; Hajek, R.A.; Hollenbach, K.; Jones, L.A.; Karanja, N.; Madlensky, L.; Marshall, J.; Newman, V.A.; Ritenbaugh, C.; Thomson, C.A.; Wasserman, L.; Stefanick, M.L. Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial. JAMA 2007, 298(3), 289–298.
  • Lee, I.M.; Cook, N.R.; Manson, J.E.; Buring, J.E.; Hennekens, C.H. Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study. J Natl Cancer Inst 1999, 91(24), 2102–2106.
  • Lee, I.M.; Cook, N.R.; Gaziano, J.M.; Gordon, D.; Ridker, P.M.; Manson, J.E.; Hennekens, C.H.; Buring, J.E. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA 2005, 294(1), 56–65.
  • Lin, J.; Cook, N.R.; Albert, C.; Zaharris, E.; Gaziano, J.M.; Van Denburgh, M.; Buring, J.E.; Manson, J.E. Vitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trial. J Natl Cancer Inst 2009, 101(1), 14–23.
  • Zhang, S.M.; Cook, N.R.; Albert, C.M.; Gaziano, J.M.; Buring, J.E.; Manson, J.E. Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial. JAMA 2008, 300(17), 2012–2021.
  • Shin, M.H.; Holmes, M.D.; Hankinson, S.E.; Wu, K.; Colditz, G.A.; Willett, W.C. Intake of dairy products, calcium, and vitamin D and risk of breast cancer. J Natl Cancer Inst 2002, 94(17), 1301–1311.
  • Missmer, S.A.; Smith-Warner, S.A.; Spiegelman, D.; Yaun, S.S.; Adami, H.O.; Beeson, W.L.; Van Den Brandt, P.A.; Fraser, G.E.; Freudenheim, J.L.; Goldbohm, R.A.; Graham, S.; Kushi, L.H.; Miller, A.B.; Potter, J.D.; Rohan, T.E.; Speizer, F.E.; Toniolo, P.; Willett, W.C.; Wolk, A.; Zeleniuch-Jacquotte, A.; Hunter, D.J. Meat and dairy food consumption and breast cancer: a pooled analysis of cohort studies. Int J Epidemiol 2002, 31(1), 78–85.
  • Chlebowski, R.T.; Johnson, K.C.; Kooperberg, C.; Pettinger, M.; Wactawski-Wende, J.; Rohan, T.; Rossouw, J.; Lane, D.; O'sullivan, M.J.; Yasmeen, S.; Hiatt, R.A.; Shikany, J.M.; Vitolins, M.; Khandekar, J.; Hubbell, F.A.; Women's Health Initiative Investigators. Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst 2008, 100(22), 1581–1591.
  • Wu, A.H.; Yu, M.C.; Tseng, C.C.; Pike, M.C. Epidemiology of soy exposures and breast cancer risk. Br J Cancer 2008, 98(1), 9–14.
  • Hsieh, C.Y.; Santell, R.C.; Haslam, S.Z.; Helferich, W.G. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res 1998, 58(17), 3833–3838.
  • Dip, R.; Lenz, S.; Anignac, J.P.; Le Bizec, B.; Gmuender, H.; Naegeli, H. Global gene expression profiles induced by phytoestrogens in human breast cancer cells. Endocr Relat Cacner 2008, 15(1), 161–173.
  • Zava, D.T.; Duwe, G. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer 1997, 27(1), 31–40.
  • Kuiper, G.G.; Lemmen, J.G.; Carlsson, B.; Corton, J.C.; Safe, S.H.; Van Der Saag, P.T.; Van Der Burg, B.; Gustafsson, J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998, 139(10), 4252–4263.
  • Lin, J.; Cook, N.R.; Albert, C.; Zaharris, E.; Gaziano, J.M.; Van Denburgh, M.; Buring, J.E.; Manson, J.E. Vitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trial. J Natl Cancer Inst 2009, 101(1), 14–23.
  • Willett, W.C.; Rockhill, B.; Hankinson, S.E.; Hunter, D.; Colditz, G.A. Nongenetic factors in the causation of breast cancer. In Diseases of the Breast, J.R. Harris, M.E. Lippman, M. Morrow, and C.K. Osborne (eds.). Philadelphia: Lippincott Williams and Wilkins, 2004, 246–249.
  • Kushi, L.H.; Fee, R.M.; Sellers, T.A.; Zheng, W.; Folsom, A.R. Intake of vitamins A, C, and E and postmenopausal breast cancer. The Iowa Women's Health Study. Am J Epidemiol 1996, 144(2), 165–174.
  • Lopez-Saez, J.B.; Senra-Varela, A.; Pousa-Estevez, L. Selenium in breast cancer. Oncology 2003, 64(3), 227–231.
  • Ganmaa, D.; Willett, W.C.; Li, T.Y.; Feskanich, D.; van Dam, R.M.; Lopez-Garcia, E.; Hunter, D.J.; Holmes, M.D. Coffee, tea, caffeine and risk of breast cancer: a 22-year follow-up. Int J Cancer 2008, 122(9), 2071–2076.
  • Ishitani, K.; Lin, J.; Manson, J.E.; Buring, J.E.; Zhang, S.M. Caffeine consumption and the risk of breast cancer in a large prospective cohort of women. Arch Intern Med 2008, 168(18), 2022–2031.
  • U.S. Department of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, CDC, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2004. (http://www.cdc.gov/tobacco/data_statistics/sgr/2004/index.htm)
  • U.S. Department of Health and Human Services. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2006. (http://www.surgeongeneral.gov/library/secondhandsmoke)
  • Pirie, K.; Beral, V.; Peto, R.; Roddam, A.; Reeves, G.; Green, J. Passive smoking and breast cancer in never smokers: prospective study and meta-analysis. Int J Epidemiol 2008, 37(5), 1069–1079.
  • Van Den Brandt, P.A.; Spiegelman, D.; Yaun, S.S.; Adami, H.O.; Beeson, L.; Folsom, A.R.; Fraser, G.; Goldbohm, R.A.; Graham, S.; Kushi, L.; Marshall, J.R.; Miller, A.B.; Rohan, T.; Smith-Warner, S.A.; Speizer, F.E.; Willett, W.C.; Wolk, A.; Hunter, D.J. Pooled analysis of prospective cohort studies on height, weight and breast cancer risk. Am J Epidemiol 2000, 152, 514–527.
  • Eliassen, A.H.; Colditz, G.A.; Rosner, B.; Willett, W.C.; Hankinson, S.E. Adult weight change and risk of postmenopausal breast cancer. JAMA 2006, 296, 193–201.
  • Ahn, J.; Schatzkin, A.; Lacey, J.V. Jr; Albanes, D.; Ballard-Barbash, R.; Adams, K.F.; Kipnis, V.; Mouw, T.; Hollenbeck, A.R.; Leitzmann, M.F. Adiposity, adult weight change and postmenopausal breast cancer risk. Arch Intern Med 2007, 167, 2091–2102.
  • Kelsey, J.L.; Fischer, D.B.; Holford, T.R.; LiVoisi, V.A.; Mostow, E.D.; Goldenberg, I.S.; White, C. Exogenous estrogens and other factors in the epidemiology of breast cancer. J Natl Cancer Inst 1981, 67, 327–333.
  • Lew, J.Q.; Freedman, N.D.; Leitzmann, M.F.; Brinton, L.A.; Hoover, R.N.; Hollenbeck, A.R.; Schatzkin, A.; Park, Y. Alcohol and risk of breast cancer by histologic type and hormone receptor status in postmenopausal women: the NIH-AARP Diet and Health Study. Am J Epidemiol 2009, 170, 308–317.
  • Bernstein, L.; Patel, A.V.; Ursin, G.; Sullivan-Halley, J.; Press, M.F.; Deapen, D.; Berlin, J.A.; Daling, J.R.; McDonald, J.A.; Norman, S.A.; Malone, K.E.; Strom, B.L.; Liff, J.; Folger, S.G.; Simon, M.S.; Burkman, R.T.; Marchbanks, P.A.; Weiss, L.K.; Spirtas, R. Lifetime recreational exercise activity and breast cancer risk among black women and white women. J Natl Cancer Inst 2005, 97(22), 1671–1679.
  • McTiernan, A.; Kooperberg, C.; White, E.; Wilcox, S.; Coates, R.; Adams-Campbell, L.L.; Woods, N.; Ockene, J. Recreational physical activity and the risk of breast cancer in postmenopausal women: the Women's Health Initiative Cohort Study. JAMA 2003, 290(10), 1331–1336.
  • Patel, A.V.; Callel, E.E.; Bernstein, L.; Wu, A.H.; Thun, M.J. Recreational physical activity and risk of postmenopausal breast cancer in a large cohort of US women. Cancer Causes Control 2003, 14(6), 519–529.
  • Bardia, A.; Hartmann, L.C.; Vachon, C.M.; Vierkant, R.A.; Wang, A.H.; Olson, J.E.; Sellers, T.A.; Cerhan, J.R. Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status. Arch Intern Med 2006, 166(22), 2478–2483.
  • Maruti, S.S.; Willett, W.C.; Feskanich, D.; Rosner, B.; Colditz, G.A. A prospective study of age-specific physical activity and premenopausal breast cancer. J Natl Cancer Inst 2008, 100(10), 728–737.
  • Willett, W.C.; Rockhill, B.; Hankinson, S.E.; Hunter, D.; Colditz, G.A. Nongenetic factors in the causation of breast cancer. In Diseases of the Breast, 3rd edition, J.R. Harris, M.E. Lippman, M. Morrow, and C.K. Osborne (eds.). Philadelphia: Lippincott Williams and Wilkins, 2004, 253.
  • Thune, I.; Brenn, T.; Lund, E.; Gaard, M. Physical activity and the risk of breast cancer. N Engl J Med 1997, 336(18), 1269–1275.
  • Brinton, L.A.; Bernstein, L.; Colditz, G.A. Summary of the workshop: workshop on physical activity and breast cancer, November 13–14, 1997. Cancer 1998, 83, 595.
  • Lee, I.M.; Cook, N.R.; Rexrode, K.M.; Buring, J.E. Lifetime physical activity and risk of breast cancer. Br J Cancer 2001, 85(7), 962–965.
  • McTiernan, A.; Tworoger, S.S.; Ulrich, C.M.; Yasui, Y.; Irwin, M.L.; Rajan, K.B.; Sorensen, B.; Rudolph, R.E.; Bowen, D.; Stanczyk, F.Z.; Potter, J.D.; Schwartz, R.S. Effect of exercise on serum estrogens in postmenopausal women: a 12-month randomized clinical trial. Cancer Res 2004, 64(8), 2923–2928.
  • Gail, M.H.; Costantino, J.P. Validating and improving models for projecting the absolute risk of breast cancer. J Natl Cancer Inst 2001, 93, 334–335.
  • Gail, M.H.; Costantino, J.P.; Pee, D.; Bondy, M.; Newman, L.; Selvan, M.; Anderson, G.L.; Malone, K.E.; Marchbanks, P.A.; McCaskill-Stevens, W.; Norman, S.A.; Simon, M.S.; Spirtas, R.; Ursin, G.; Bernstein, L. Projecting individualized absolute invasive breast cancer risk in African American women. J Natl Cancer Inst 2007, 99, 1782–1792.
  • Claus, E.B.; Risch, N.; Thompson, W.D. Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer 1994, 73, 643–651.
  • Berry, D.A.; Iversen, E.S. Jr; Gudbjartsson, D.F.; Hiller, E.H.; Garber, J.E.; Peshkin, B.N.; Lerman, C.; Watson, P.; Lynch, H.T.; Hilsenbeck, S.G.; Rubinstein, W.S.; Hughes, K.S.; Parmigiani, G. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol 2002, 20, 2701–2712.
  • Antoniou, A.C.; Cunningham, A.P.; Peto, J.; Evans, D.G.; Lalloo, F.; Narod, S.A.; Risch, H.A.; Eyfjord, J.E.; Hopper, J.L.; Southey, M.C.; Olsson, H.; Johannsson, O.; Borg, A.; Pasini, B.; Radice, P.; Manoukian, S.; Eccles, D.M.; Tang, N.; Olah, E.; Anton-Culver, H.; Warner, E.; Lubinski, J.; Gronwald, J.; Gorski, B.; Tryggvadottir, L.; Syrjakoski, K.; Kallioniemi, O.P.; Eerola, H.; Nevanlinna, H.; Pharoah, P.D.; Easton, D.F. The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Brit J Cancer 2008, 98, 1457–1466.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.